Currently, the company’s device, Optune, has been approved by the US FDA for the treatment of glioblastoma and mesothelioma. Looking at a wider …
Source link : https://www.bollyinside.com/news/is-the-rally-in-novocures-stock-being-exaggerated/
Author :
Publish date : 2020-12-31 16:18:45
Copyright for syndicated content belongs to the linked Source.
Author : mesothelioma
Publish date : 2021-01-01 22:16:12
Copyright for syndicated content belongs to the linked Source.